Senior Manager, Caduet Global Brand Leader, Pfizer
At 22, Stephanie Bova left the United States to teach English in Japan. It would be a decision that ultimately determined
her success today as a prominent figure in pharmaceutical marketing at one of the largest companies in the world. As global
brand team leader for Caduet, Pfizer's single-pill combination of Norvasc and Lipitor for treatment of high blood pressure
and cholesterol, Bova oversees development, regulatory, medical commercial, and outcomes research. In the past six months,
her team has launched Caduet in Spain, Romania, and Russia, and anticipates approval in up to five additional countries by
the end of 2009.
Well recognized for her achievement within the cardiovascular marketing department at Pfizer, Bova says she has "been so lucky
to work on a medicine like Lipitor which has helped people like my father lower his very high cholesterol and my uncle avoid
another heart attack." In terms of innovation, she believes there is room for improvement: "We have brilliant scientists and
outstanding strategists. However, we are a very structured industry. We need to learn to be more agile and to embrace the
need for speed."
Outside Pfizer, Bova is deeply involved in the Healthcare Businesswomen's Association (HBA) Metro chapter and is set to become
President elect of the nonprofit in 2010. The emerging pharma leadership nominations that Bova received shared positive feedback
but made one idea very clear: A next Big Pharma CEO may be in our midst.